Charleston Chua, MD
Plastic and Reconstructive Surgery · San Diego, CANPI 1881937449
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.9%), food and beverage and education — rather than concentrated in one kind of arrangement. Kerecis Limited accounts for 74.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2024 at $9,990 and has fallen 50.5% since, to $4,943 in 2025.
Across 75 payments — averaging $205.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$12K
- TELA Bio, Inc.$741
- Acumed LLC$732
- Kls-martin L.p.$554
- Motiva USA, LLC$416
- AbbVie$310
- plus $1K from 14 others
What the payments were for
- Consulting fees$4503%
- Speaking & faculty fees$5,85038%
- Travel & lodging$1,64611%
- Food & beverage$5,22534%
- Education$2,25015%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 16 | $11,518 |
| TELA Bio, Inc. | 9 | $741 |
| Acumed LLC | 8 | $732 |
| Kls-martin L.p. | 3 | $554 |
| Motiva USA, LLC | 5 | $416 |
| AbbVie(2 entities) | 3 | $310 |
| Integra Lifesciences Corporation | 4 | $288 |
| Biotissue Holdings Inc. | 3 | $137 |
| E.r. Squibb & Sons, L.L.C. | 5 | $123 |
| Endo Pharmaceuticals Inc. | 1 | $122 |
| Mentor Worldwide LLC | 3 | $100 |
| Avita Medical Americas, LLC | 2 | $81 |
| Galderma Laboratories, L.p. | 4 | $64 |
| Aroa Biosurgery Incorporated | 3 | $52 |
| Davol Inc. | 1 | $43 |
| Smith+Nephew | 1 | $41 |
| Sanara Medtech Inc. | 1 | $30 |
| Bone Support Inc. | 1 | $28 |
| Merz North America, Inc. | 1 | $23 |
| Revance Therapeutics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$35,486
- Kerecis SurgiClose$9,600
- Kerecis Omega3 SurgiClose$8,872
- Kerecis GraftGuide$2,400
- ACUMED$710
- INTEGRA$356
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex)$307
- INnate Implant$293
- Motiva Implant Matrix$284
- OviTex 2S$163
- NATRELLE$151
- NATRELLE SALINE-FILLED BREAST IMPLANTS$124
- XIAFLEX$122
- INTEGRA DERMAL REGENERATION TEMPLATE$119
- PRIMATRIX$119
How this compares
$15,421 in reported general payments places this provider in the 85th percentile of 349 plastic and reconstructive surgery providers in California.
See all plastic and reconstructive surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in San Diego
- Manish ChampaneriaSan Diego$16K
- Jourdain ArtzSan Diego$11K
- Mark SuskiThousand Oaks$294K
- Corey MaasSan Francisco$286K
- Arian MowlaviLaguna Beach$250K
- Charles LeeSan Francisco$200K
- David SieberSan Francisco$195K
- David KulberLos Angeles$194K
- Matthew NykielUpland$181K
- Subhas GuptaLoma Linda$178K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.